
Timothy Chan
@GeneCollector
Followers
5K
Following
15K
Media
426
Statuses
7K
Chair, Global Center for Immunotherapy, Cleveland Clinic Health System, @ClevelandClinic; Professor of Medicine; fan of tennis, coral reefs, Legos; views my own
Cleveland, OH
Joined April 2017
RT @DrJohnSuh: Congratulations 🎊 to our graduating #radonc residents @DBuchbergerMD @SeanParkerMD & @BillenaMd who will be heading to….
0
6
0
RT @lungoncdoc: Before and After. Just 8 weeks. Nope, not lymphoma. THIS is non-small cell lung cancer. THIS is why molecular profiling m….
0
91
0
RT @LauraBukavinaMD: Excited for an amazing weekend as the brilliant Phil Abbosh from @FoxChaseCancer joins us @CleClinicUro to teach inspi….
0
5
0
RT @jamecancerdoc: It is wonderful to be part of one of the cancer hospitals in the world as per @Newsweek https:….
0
11
0
RT @Nature: From today, all new submissions to Nature that are published will be accompanied by referees’ reports and author responses — to….
0
238
0
RT @FierceBiotech: The FDA is introducing a new priority voucher program designed to shorten the drug review process from 10 to 12 months d….
0
10
0
RT @scottwongDC: BREAKING @NBCNews: Two Democratic state lawmakers have been shot in “politically motivated” shooting in eastern Minnesot….
0
32
0
RT @NIH: Transparency is the cornerstone of NIH research. Recently, NIH has implemented new transparency measures for Institutional Biosafe….
0
19
0
RT @McFaul: This is un-American. Set your partisan politics aside, be a patriot, and denounce this awful, antidemocratic act.
0
721
0
RT @IASLC: Five years into the CROWN study, this follow-up shows that #lorlatinib efficacy and safety in the Asian subgroup continue to be….
0
4
0
RT @drmpk91: Phase 2 Trials on Induction Chemoimmunotherapy, Radiation, and Consolidation IO in Stage III EGFR–Wild-Type NSCLC.Source: http….
0
3
0
RT @DeryaTR_: Meet the heroes of the immune system. I’ve worked with all of them, pretty cool guys! I’ll be telling their adventures in a….
0
13
0
RT @PTarantinoMD: One week to #ASCO25. Which will be an unprecedented ASCO for breast oncologists. Treatment algorithms will change for ALL….
0
133
0
RT @MarkMishraMD: #ASCO25 Final CATNON trial results confirm: adjuvant TMZ (not concurrent) improves OS in IDH-mut anaplastic glioma (12.5….
0
17
0